You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Gynaecological conditions
  5. Endometriosis and fibroids

Linzagolix for treating symptoms of endometriosis

  • Technology appraisal guidance
  • Reference number: TA1067
  • Published:  04 June 2025
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Final draft guidance
  2. Invitation to participate
  3. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6357

History

Documents created during the development process.

Final draft guidance

  • Final draft guidance

  • Final draft guidance (PDF 99 KB)

    Published:
    01 May 2025
  • Equality impact assessment (downloadable version) (PDF 119 KB)

    Published:
    01 May 2025
  • Committee papers (PDF 9.5 MB)

    Published:
    24 June 2025

Invitation to participate

  • Equality impact assessment (scoping) (PDF 111 KB)

    Published:
    28 August 2024
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 149 KB)

    Published:
    28 August 2024
  • Final stakeholder list (PDF 138 KB)

    Published:
    28 August 2024
  • Final scope (PDF 144 KB)

    Published:
    28 August 2024

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6357

  • Draft scope post referral (PDF 210 KB)

    Published:
    14 March 2024
  • Draft matrix post referral (PDF 175 KB)

    Published:
    14 March 2024
Back to top